Aflac Incorporated

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +35

Aflac clears an all-time high, shares trade near record levels - Ad-hoc-news.de

AI-generated analysis

πŸ“ˆ Aflac shares hit a fresh all-time high of roughly $119.85, surpassing the previous 52-week peak of $119.81.

πŸ’° The company reported first-quarter 2026 revenue of $4.35 billion, exceeding expectations of $4.18 billion.

πŸ“‰ Adjusted earnings per share came in slightly below consensus estimates for the quarter.

🀝 Analyst consensus remains 'Hold' with an average price target of $112.09, which is lower than current trading levels.

πŸ’΅ Aflac has increased its dividend for 42 consecutive years, reflecting a consistent capital-return policy.

πŸ“Š The stock trades at a P/E multiple near 13.4 with a current dividend yield of approximately 2 percent.

🏒 Aflac generates revenue primarily from supplemental health and life insurance policies in the US and Japan.

πŸ“… As of June 25, 2026, the stock traded at around $118.40 with a market cap of $60.26 billion.

Bullish Signals
  • Aflac shares reached a new all-time high of approximately $119.85, indicating strong investor interest and price appreciation.
  • The company reported first-quarter 2026 revenue of $4.35 billion, which beat analyst expectations of $4.18 billion.
  • Aflac has successfully increased its dividend for 42 consecutive years, demonstrating a long-term commitment to shareholder returns.
  • The stock maintains a moderate valuation with a P/E multiple near 13.4 and a stable dividend yield around 2 percent.
Risk Factors
  • Analyst consensus ratings are muted, with 11 Wall Street analysts holding a 'Hold' rating on the stock.
  • The average analyst price target of $112.09 is significantly below the current trading price, suggesting limited upside in some models.
  • Adjusted earnings per share for the first quarter came in slightly below consensus estimates, indicating mixed operational performance.
Full Analysis
Aflac Inc. shares reached a new all-time high of approximately $119.85 on the New York Stock Exchange, trading near record levels around $118.40 as of June 25, 2026. This milestone follows a robust multi-year streak of dividend increases and steady earnings performance, with the stock currently valued at a market capitalization of roughly $60.26 billion. Despite the positive share price momentum, Wall Street sentiment remains cautious. A consensus of 11 analysts rates the stock as a 'Hold,' with an average price target of $112.09 sitting below current trading prices. The company maintains a moderate valuation profile with a price-to-earnings multiple near 13.4 and a dividend yield around 2 percent. Fundamentally, Aflac reported strong first-quarter 2026 revenue of approximately $4.35 billion, beating analyst expectations of $4.18 billion. However, adjusted earnings per slightly missed consensus estimates, resulting in a mixed but resilient quarterly picture for the supplemental health and life insurance provider.